Clezutoclax

SKU: orb2278506

Description

Clezutoclax is a potent and selective Bcl-XL inhibitor, making it an effective payload for antibody-drug conjugate (ADC) development. It is used in cancer research to study apoptosis induction in vitro and evaluate targeted tumor therapy in vivo.

Research Area

Cell Biology

Key Properties

• CAS Number: 1949843-71-3
• MW: 1715.89
• Formula: C₈₃H₁₀₂N₁₂O₂₄S₂
• SMILES: C(C12CC3(OCCN(C(OCC4=C(CC[C@@H]5O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]5O)C=C(NC([C@@H](NC([C@@H](NC(CN6[C@H](COCCS(=O)(=O)O)C[C@@H](C6=O)N7C(=O)C=CC7=O)=O)[C@H](C)C)=O)C)=O)C=C4)=O)CC[C@@H](CO)O)CC(C)(C1)CC(C)(C2)C3)N8C(C)=C(C=N8)C9=C(C(O)=O)N=C(C=C9)N%10CC%11=C(C(NC%12=NC=%13C(S%12)=CC=CC%13)=O)C=CC=C%11CC%10
• Target: Bcl-2 Family,Drug-Linker Conjugates for ADC,ADC Cytotoxin

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

124082768